MedTrace Logo

Biphasic Ventilation Airway Management Clinical Trial

NCT03042598 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2017-02-03

No results posted yet for this study

Summary

Investigators intend to determine if the use of Biphasic Cuirass Ventilation (BCV) improves patient safety (avoiding hypoxia) during emergency rapid sequence intubation .

Conditions

  • Intubation

Interventions

DEVICE

Biphasic Cuirass Ventilation

The RTX Respirator will be applied to the patient's chest to provide non-invasive ventilatory support using a Biphasic Cuirass Ventilation technology to increase the safe apnic period during intubation.

Sponsors & Collaborators

  • University Medical Center of Southern Nevada

    lead OTHER

Principal Investigators

  • David E Slattery, MD · University Medical Center of Southern Nevada

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-14
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03042598 on ClinicalTrials.gov